A Universal System for Highly Efficient Cardiac Differentiation of Human Induced Pluripotent Stem Cells That Eliminates Interline VariabilityPaul W. Burridge, Elias T. Zambidis|PLoS ONE|2011Cited by 422
Alternative-Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Nonmalignant DisordersOrly R. Klein, Heather J. Symons, Allen Chen et al.|Biology of Blood and Marrow Transplantation|2016Cited by 76
Nonmyeloablative Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide for Pediatric and Young Adult Patients with High-Risk Hematologic MalignanciesOrly R. Klein, Heather J. Symons, Jessica Buddenbaum et al.|Biology of Blood and Marrow Transplantation|2016Cited by 73
Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adultsHeather J. Symons, Ephraim J. Fuchs, Marianna Zahurak et al.|Blood Advances|2020Cited by 73
Single-Agent Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis after Human Leukocyte Antigen–Matched Related Bone Marrow Transplantation for Pediatric and Young Adult Patients with Hematologic MalignanciesElad Jacoby, Heather J. Symons, Allen Chen et al.|Biology of Blood and Marrow Transplantation|2015Cited by 46